18.12.2012 Views

joint strategic needs assessment foundation profile - JSNA

joint strategic needs assessment foundation profile - JSNA

joint strategic needs assessment foundation profile - JSNA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Interative Hull Atlas: www.hullpublichealth.org/Pages/hull_atlas.htm More information: www.jsnaonline.org and www.hullpublichealth.org<br />

Table 240: Five Year Cancer Relative Survival Rates in Humber and Yorkshire Coast<br />

Cancer Network<br />

Five-year relative survival rates in Humber and Yorkshire Coast<br />

Network (cases diagnosed 1999-2003)<br />

Cancer type and ICD 10 coding<br />

Males Females<br />

Cohort Deaths<br />

Surviving %<br />

(95% CI)<br />

Cohort Deaths<br />

Surviving %<br />

(95% CI)<br />

All cancers (C00-C97)* 11,785 7,901 42 (41, 43) 11,460 6,377 53 (52, 54)<br />

Lip, oral, pharynx (C00-C14) 285 138 61 (54, 68) 153 75 60 (51, 70)<br />

Head & neck (C00-C14, C30-C32, C73) 496 248 59 (54, 65) 277 112 69 (62, 76)<br />

Oesophagus (C15) 411 381 9 (6, 12) 238 223 8 (4, 13)<br />

Stomach (C16) 511 462 13 (9, 16) 276 240 18 (12, 23)<br />

Colorectal (C18-C21) 1,647 1,032 48 (45, 51) 1,263 745 53 (49, 56)<br />

Pancreas (C25) N/A N/A<br />

Larynx (C32) 173 95 54 (45, 63) 35 11 77 (60, 95)<br />

Lung (C33-C34) 2,148 2,033 7 (6, 8) 1,353 1,265 8 (6, 10)<br />

Malignant melanoma of skin (C43)<br />

Mesothelioma (C45)**<br />

204 61 80 (73, 88) 304 56 91 (86, 96)<br />

Breast (C50) 23 10 75 (48, 103) 3,444 969 82 (80, 84)<br />

Cervix uteri (C53) N/A 328 91 77 (71, 82)<br />

Corpus uteri (C54) N/A 453 146 78 (73, 83)<br />

Ovary (C56-C574) N/A 598 386 41 (36, 45)<br />

Prostate (C61) 2,521 1,091 77 (74, 79) N/A<br />

Testis (C62) 159 18 90 (85, 95) N/A<br />

Kidney/urinary (C64-C66, C68) 329 186 53 (46, 59) 225 138 46 (39, 54)<br />

Bladder (C67) 621 361 58 (52, 63) 267 187 41 (33, 49)<br />

Brain (C71) 210 186 13 (8, 18) 160 141 13 (8, 19)<br />

Hodgkin's disease (C81) 80 21 77 (67, 88) 51 14 77 (63, 90)<br />

Non-Hodgkin's lymphoma (C82-C85, C96) 447 238 57 (51, 63) 331 148 65 (59, 72)<br />

Lymphoid leukaemia (C91) 291 111 76 (69, 83) 174 65 78 (69, 87)<br />

Myeloid leukaemia (C92) 140 111 26 (18, 35) 137 102 33 (23, 42)<br />

Leukaemia (C91-C95) 437 228 59 (53, 65) 315 171 58 (51, 65)<br />

Other haematological (C88-C90) 191 135 38 (29, 46) 187 135 34 (26, 43)<br />

*Excluding non-melanoma skin (C44).<br />

**5-year survival data were not available at time of publication<br />

Survival rates at PCT level are not routinely produced, but are available on request from<br />

NYCRIS provided the numbers of cases are large enough so that confidentiality is not<br />

an issue and the number of deaths is sufficient for meaningful estimates to be produced.<br />

Five year relative survival rates for cases diagnosed during 1998-2002 and 2000-2002<br />

are available for Hull for lung cancer (within section 10.2.2.5 on page 540), colorectal<br />

cancer (within section 10.2.3.5 on page 552) and breast cancer (within section<br />

10.2.5.5 on page 561).<br />

10.2.1.8 Screening<br />

See specific section on screening above on page 416.<br />

Joint Strategic Needs Assessment Foundation Profile – Hull Health Profile: Release 3. March 2011. 522

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!